Arcus Biosciences, Inc. IPO Research Information

Arcus Biosciences, Inc. IPO Advisory

Share this IPO Profile:

Smart Search

For IPO Boutique's "scale of 1 to 5" BUY rating on Arcus Biosciences, Inc., and our comprehensive analysis, click "Buy Market Research".

Company	Symbol	Price Range	Issue Price	Open	Shares	Trade Date
Arcus Biosciences, Inc.	RCUS - NYSE	$13.00-$15.00	$15.00	$20.00	8 million	3/15/2018
Underwriter(s): Citigroup, Goldman Sachs & Co., Leerink Partners
Co-Manager(s):
Industry: Health Care
Filing(s): Filed 2018-02-16 Terms Added 2018-03-05 Final Prospectus 2018-03-16

Arcus Biosciences, Inc. Quote & Chart - Click for current quote - RCUS

About Arcus Biosciences, Inc. (adapted from Arcus Biosciences, Inc. prospectus):
They are a clinical-stage biopharmaceutical company focused on creating innovative cancer immunotherapies by leveraging underexploited biological opportunities.

This description is adapted from prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.

IPO Boutique aggregates information on public companies and private companies, such as "RCUS" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.